Global Molecular Diagnostics Cancer Oncology Market Size, Strategy and Forecasts 2016 to 2019
February 29, 2016 05:48 ET
|
Research and Markets
Dublin, Feb. 29, 2016 (GLOBE NEWSWIRE) -- Research and Markets (http://www.researchandmarkets.com/research/639jbs/molecular) has announced the addition of the "Molecular Diagnostics...
Global Clinical Laboratory, Molecular Diagnostics and Genomic Testing Services Market Trends and Forecasts 2016 to 2019
January 27, 2016 04:59 ET
|
Research and Markets
Dublin, Jan. 27, 2016 (GLOBE NEWSWIRE) -- Research and Markets (http://www.researchandmarkets.com/research/dp5zlw/clinical) has announced the addition of the "Clinical Laboratory,...
Global In-Vitro Diagnostic Testing Services Market Forecasts 2015-2019
January 19, 2016 03:36 ET
|
Research and Markets
Dublin, Jan. 19, 2016 (GLOBE NEWSWIRE) -- Research and Markets (http://www.researchandmarkets.com/research/4qbq3q/in_vitro) has announced the addition of the "In Vitro Diagnostic...
Timothy Henn, Experienced Genomics Diagnostics and Life Sciences Executive, Joins CardioDx as Chief Financial Officer
December 14, 2015 08:00 ET
|
CardioDx
REDWOOD CITY, CA--(Marketwired - Dec 14, 2015) - CardioDx, Inc., a molecular diagnostics company specializing in cardiovascular genomics, announced today the appointment of Timothy Henn as Chief...
Global Genetic Testing Market Size, Strategies and Forecasts Report 2016-2020
December 10, 2015 04:01 ET
|
Research and Markets
Dublin, Dec. 10, 2015 (GLOBE NEWSWIRE) -- Research and Markets (http://www.researchandmarkets.com/research/p7h35d/the_global) has announced the addition of the "The Global Genetic...
Multi-Center, Community-Based Patient Registry Interim Results Presented at the AHA Scientific Sessions Support the Clinical Utility of the Corus(R) CAD Test in the Assessment of Obstructive Coronary Artery Disease
November 10, 2015 08:11 ET
|
CardioDx
REDWOOD CITY, CA--(Marketwired - Nov 10, 2015) - CardioDx, Inc., a molecular diagnostics company specializing in cardiovascular genomics, announced today results from a multi-center,...
CardioDx Announces Positive Data From a Large Primary Care Registry on the Impact of the Corus CAD Test in the Assessment of Obstructive Coronary Artery Disease in Women
September 30, 2015 08:00 ET
|
CardioDx
REDWOOD CITY, CA--(Marketwired - Sep 30, 2015) - CardioDx, Inc., a molecular diagnostics company specializing in cardiovascular genomics, announced today results from a subgroup analysis of the...
CardioDx Expands Patient Access to the Corus(R) CAD Test Through National Agreement With Quest Diagnostics
September 16, 2015 08:30 ET
|
CardioDx
REDWOOD CITY, CA--(Marketwired - Sep 16, 2015) - CardioDx, Inc., a molecular diagnostics company specializing in cardiovascular genomics, today announced a national specimen-draw agreement with...
Prospective Patient Registry Demonstrates the Corus(R) CAD Test Score Impacts Real-World Clinical Decision-Making in Patients Presenting With Symptoms Suggestive of Obstructive Coronary Artery Disease
May 18, 2015 08:00 ET
|
CardioDx
REDWOOD CITY, CA--(Marketwired - May 18, 2015) - CardioDx, Inc., a molecular diagnostics company specializing in cardiovascular genomics, announced today results from a multi-center,...
European Clinical Laboratory, Molecular Diagnostics and Genomic Testing Services Market 2015-2019: Next Generation Sequencing and new Molecular Diagnostics Tests drive market growth while lowering costs
May 05, 2015 06:34 ET
|
Research and Markets
Dublin, May 05, 2015 (GLOBE NEWSWIRE) -- Research and Markets (http://www.researchandmarkets.com/research/pmd597/clinical) has announced the addition of the "Clinical Laboratory,...